Fennec Pharmaceuticals (FENC) Interest Expenses (2014 - 2026)
Fennec Pharmaceuticals' (FENC) quarterly Interest Expenses came in at $2.4 million in Q4 2025, up 232.59% YoY from $718000.0 in Q4 2024, and up 307.51% on a QoQ basis from $586000.0 in Q3 2025.
Fennec Pharmaceuticals (FENC) Interest Expenses (2014 - 2026) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 10 years of Interest Expenses data on file, last reported at $2.4 million in Q4 2025.
- Quarterly Interest Expenses rose 232.59% year-over-year to $2.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.2 million (up 8.87% YoY) and the FY2025 annual result came in at $46.5 million, down 11.17% from the prior year.
- Interest Expenses advanced to $2.4 million in Q4 2025, from $586000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $2.4 million in Q4 2025 to a low of $4000.0 in Q1 2021.
- A 5-year average of $629250.0 and a median of $656000.0 in 2024 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2021 — Interest Expenses slumped 99.8% — and 2022, when it jumped 1350.0%.
- Tracing FENC's Interest Expenses over 5 years: stood at $62000.0 in 2021, then soared by 1100.0% to $744000.0 in 2022, then advanced by 22.98% to $915000.0 in 2023, then dropped by 21.53% to $718000.0 in 2024, then surged by 232.59% to $2.4 million in 2025.
- The last three Interest Expenses figures came in at $2.4 million (Q4 2025), $586000.0 (Q3 2025), and $594000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn | 3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,000.00 |
| Jun 30, 2026 | 3,000.00 |
| Dec 31, 2025 | 2.39 Mn |
| Dec 31, 2025 | 2.39 Mn |
| Sep 30, 2025 | 586,000.00 |
| Sep 30, 2025 | 586,000.00 |
| Jun 30, 2025 | 594,000.00 |
| Jun 30, 2025 | 594,000.00 |
| Mar 31, 2025 | 592,000.00 |
| Mar 31, 2025 | 592,000.00 |
| Dec 31, 2024 | 718,000.00 |
| Dec 31, 2024 | 718,000.00 |
| Sep 30, 2024 | 1.03 Mn |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | 1.03 Mn |
| Mar 31, 2024 | 1.03 Mn |
| Dec 31, 2023 | 915,000.00 |
| Dec 31, 2023 | 915,000.00 |